跳至主要内容
临床试验/NCT02506322
NCT02506322已完成不适用

Adjuvant Psychotherapy for Relapse Prevention in Early Adulthood (< 35 yr.) of Bipolar Disorder

University Hospital Tuebingen2 个研究点 分布在 1 个国家目标入组 318 人开始时间: 2015年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
318
试验地点
2
主要终点
Time to new affective episode

研究概览

简要总结

This efficacy study compares an adjuvant specific psychotherapy and an active control intervention for Bipolar Disorder under mood stabilizer to prevent relapse an maintain remission. Patients should be in their early (18-30 yr.) phase of illness without having suffered of to many affective episodes (below 6), already. In addition, psychological, social, and neurobiological mediators and moderators well be identified.

详细描述

There is still a lack of controlled outcome and follow-up studies about the role of adjuvant psychotherapy in Bipolar Disorder. By treating older subjects having suffered of multiple affective episodes, the potential benefit of psychotherapy to prevent relapse and help to adjust to this chronic illness might be underestimated. In addition, the investigators have no knowledge of mechanism (mediators) of positive changes by successful psychotherapy and of subjects with good outcome of adjuvant psychotherapy (moderators, indicators, predictors). Possible mediators and moderators can be sociodemographic, psychological (cognitive, interactional), and/or biological (neuronal, genetic). The planned study will address all three areas of questions. In a multi-center study, 300 younger subjects suffering of a Bipolar Disorder will be included and provide with one of two treatments in addition to stable medication. Moderators and mediators are selected on promising preliminary results and based on a psycho-biological understanding of Bipolar Disorder.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Bipolar I and Bipolar II Disorder,
  • 18 to 55 years of age,
  • giving informed consent to assessment, treatment, and randomization,
  • currently remitted (for at least 4 weeks) and taking medication,
  • less than 6 previous affective episodes

排除标准

  • currently symptomatic (depressed, manic, hypomanic),
  • suicidal,
  • not taking medication,
  • schizo-affective, schizophrenic, borderline personality disorder,
  • not giving or withdrawing consent

结局指标

主要结局

Time to new affective episode

时间窗: 18 months

At baseline, subjects have to be remitted. Psychotherapies focus on maintenance and relapse prevention. Relapse will be assessed by LIFE interview every six month

次要结局

  • Social functioning(18 months)
  • Young Mania Rating Scale(18 months)
  • Qick-Inventory of Depressive Symptoms(18 months)
  • Neurobiological changes (functional, genetic) (functional MRI)(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. Martin Hautzinger

University Professor of Clinical Psychology an Psychotherapy

University Hospital Tuebingen

研究点 (2)

Loading locations...

相似试验